MAbSilico is a biotechnology company specializing in the development of computational tools and platforms for the design and optimization of monoclonal antibodies. The company focuses on leveraging advanced algorithms and artificial intelligence to enhance the efficiency and effectiveness of antibody discovery and development processes. MAbSilico aims to streamline the workflow for researchers and pharmaceutical companies by providing innovative solutions that facilitate the identification of high-quality therapeutic antibodies.